New adjunctive antidepressant elevates serotonin in Phase I trial
Drug Discovery World
APRIL 12, 2023
Evecxia Therapeutics has reported favourable safety, tolerability, pharmacokinetic, and pharmacodynamic data from a Phase I trial of EVX-101 in healthy volunteers treated with escitalopram. The post New adjunctive antidepressant elevates serotonin in Phase I trial appeared first on Drug Discovery World (DDW).
Let's personalize your content